MWMagda Wojtara

Magda Wojtara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Magda Wojtara has a total of 105 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating the performance of large language models in diagnosing rare genodermatoses

    by Magda Wojtara, Gaity Wahab

    The integration of artificial intelligence (AI) into healthcare presents an unprecedented opportunity to improve access to quality care, particularly in fields facing workforce shortages and diagnostic complexity. Dermatology exemplifies this challenge, with stark disparities in specialist access both within high-income countries and globally. These inequities are especially pronounced for individuals with rare skin disorders, such as genodermatoses—genetic conditions with multisystem involvement that are frequently underdiagnosed, misdiagnosed, and undertreated. Large language models (LLMs), such as ChatGPT, have demonstrated growing capacity to generate medically relevant content and synthesize complex information rapidly. Their potential applications in rare diseases are promising, including support in diagnosis, patient education, and clinical decision-making. However, the utility of LLMs in dermatology, particularly for rare genetic conditions, remains underexplored. This paper highlights the intersection of AI, health equity, and rare disease care, emphasizing the urgent need for robust evaluation frameworks to assess LLM outputs for accuracy, safety, clarity, empathy, and trustworthiness. As global health efforts aim to meet the needs of millions living with rare diseases, rigorous validation of AI tools is critical to ensure they reduce, rather than reinforce, existing disparities.

  • Open Access

    Exploring the potential of deep brain stimulation in managing cluster headache: a systematic review

    by Olivier Uwishema, Sanobar Shariff, Judy Ahmad El Chakik, Lydia Daniel Bisetegn, Omar Alomari, Magda Wojtara

    Background: The debilitating nature of cluster headache (CH) is typified by intense, repeated cephalgia that are often referred to as “suicide headaches” owing to their severity. Individuals may not respond appropriately to therapeutic interventions despite various alternatives being readily available. This warrants an investigation into further management options. One of the promising solutions for CH has been identified as deep brain stimulation (DBS), which specifically targets the posterior hypothalamus. Aim: This systematic review aims to summarize the current literature on the safety and efficacy of DBS in the management of CH. Method and materials: A comprehensive literature search identified 15 relevant studies comprising clinical trials, case reports, and observational studies from Embase, Web of Science, PubMed/MEDLINE, Scopus, and the Cochrane Library using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 standards. Results: The systematic review elucidated that DBS, with a focus on the posterior hypothalamus, facilitated significant reductions in the frequency, severity, and duration of cephalgic ‘attacks’ associated with CH observed. While individual responses varied, DBS was generally well-tolerated, with transient and reversible adverse effects involving focal neurological deficits (i.e., diplopia) being the most common. Importantly, long-term benefits were observed in vast populations, improving their overall quality of life. Furthermore, DBS demonstrated effects beyond localized hypothalamic stimulation, with evidence suggesting modulation of the pain processing network. Additionally, DBS was found to alleviate nocturnal CH attacks without disrupting circadian rhythms. These findings suggest that DBS holds promise as a therapeutic option for CH, particularly in individuals refractory to other treatments. Conclusion: Existing research suggests that DBS, particularly when targeting the posterior hypothalamus, can significantly reduce CH ‘attack’ frequency, severity, and duration. Further research should focus on patient selection criteria and a deeper understanding of the mechanisms underpinning DBS to optimize its effectiveness in managing such a disabling cephalgia.


  • Open Access

    Stem cell therapies and glioma stem cells in glioblastoma: a systematic review of current challenges and research directions

    by Olivier Uwishema, Sanobar Shariff, Magda Wojtara, Judy Ahmad El Chakik, Shankhaneel Ghosh, Kehinde Obamiro, Syed Ather Enam

    Glioblastoma is the most aggressive tumor of glial origin and the most common, as established by the World Health Organization. GBM has been one of the most intractable tumors with minimal progress in prognosis despite decades of research. Stem cell therapy (SCT) has raised hopes with regard to possibly targeting tumor progression and recurrence. Glioma stem cells (GSCs) are directly involved in gliomagenesis and chemoresistance, thus constituting potential valuable therapeutic targets for improving treatment outcomes. The objective of this review article is to assess and consider the potential therapeutic benefits, challenges, and prospective research directions for SCTs for glioblastoma with a particular focus on GSCs as key therapeutic targets. A literature review was performed using search terms and Boolean operators pertinent to SCT and glioblastomas to gather all existing literature. The databases PubMed/MEDLINE, Scopus, and the Cochrane Library were searched in accordance with the standard guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. The review established that the main mesenchymal stem cells (MSCs), neural stem cells (NSCs), induced pluripotent stem cells (iPSCs), and hematopoietic stem cells are the first SCTs evaluated in terms of their potential as a glioblastoma therapy. While SCTs were found to be effective in tumor targeting and immune modulation, they face certain restrictions, including death of stem cells inside the body, tumor heterogeneity, and transformation to malignancy. Research must now focus on the combination of stem cell therapy with molecular-targeted therapy and advanced delivery systems for improved tumor targeting, better overcoming resistance, and enhancing both efficacy and safety for patients undergoing treatment for glioblastoma. • MSCs, NSCs, iPSCs, and HSCs are the primary stem cell types explored in glioblastoma therapy. • GSCs, as key drivers of tumor initiation, progression, and resistance, are essential therapeutic targets. • Ongoing research and clinical trials are needed to optimize stem cell applications and improve outcomes for glioblastoma patients. • Concerns of both efficacy and safety remain regarding stem cell therapy for the treatment of glioblastoma.


  • Open Access

    Stem cell therapy use in patients with dementia: a systematic review

    by Olivier Uwishema, Malak Ghezzawi, Magda Wojtara, Ignatius N Esene, Kehinde Obamiro

    Stem cell therapy (SCT) is increasingly recognized for its potential in managing cognitive impairment, particularly that of dementia. The application of SCT aims to restore cognitive functioning in people living with dementia. Beyond pre-clinical studies, several clinical trials have evaluated specific stem cell (SC) types for their efficacy in treating dementia. To assess the status and efficacy of pre-clinical and clinical studies utilizing SCs as a therapeutic approach for dementia. A systematic review was conducted using two electronic databases: MEDLINE and Embase. We reviewed studies on the application of SCs in dementia, focusing on the following aspects: Animal models used in pre-clinical studies, tissue sources of SCs and donor species, and administrative routes and outcome assessments. Included papers comprised randomized control trials (RCTs) and original studies, while those involving adjuvant therapies for dementia were excluded. Quality assessment criteria included relevance to the research question, type of SCs, stage of SC transplantation, duration and route of administration, methods for outcome assessment, and the total number of animals implicated. A total of 32 papers were included, encompassing 21 clinical trials and 11 preclinical studies. The preclinical studies employed various transgenic animal models to evaluate SCT outcomes. Animal models of dementia, particularly transgenic mice, have proven instrumental in replicating human disease mechanisms. These models facilitate understanding of pathophysiology and preclinical testing of therapeutic interventions. Studies utilizing SCT demonstrated notable improvements in spatial memory, reduced neuroinflammation, and protection against amyloid-beta (Aβ) toxicity. Key mechanisms included modulation of inflammation, microglial immune responses, neurogenesis support, and anti-amyloidogenic effects. Preclinical studies predominantly employed human placenta-derived mesenchymal stem cells (PD-MSCs), umbilical cord-derived MSCs (U-MSCs), and induced pluripotent stem cell-derived neuronal precursors. Administration routes varied, with stereotactic and intravenous injections targeting affected brain regions. Reductions in inflammatory markers such as IL-1β, TNF-α, and increases in anti-inflammatory cytokines like IL-4 and IL-10 were observed. These outcomes emphasize the immunomodulatory and neuroprotective capacities of SCT. SCT shows promise in addressing dementia-related pathologies by leveraging diverse therapeutic mechanisms. Continued refinement of preclinical models and translational research is essential to bridge gaps between preclinical findings and clinical applications, potentially paving the way for novel treatments for dementia.


  • Open Access

    Addressing Cardiometabolic Challenges in HIV: Insights, Impact, and Best Practices for Optimal Management—A Narrative Review

    by Nadine Mugisha, Laura Ghanem, Omar A. I. Komi, Rawan Noureddine, Sanobar Shariff, Magda Wojtara, Mahlagha Mousavi Nanehkeran, Olivier Uwishema

    Introduction: Since the advent of highly active antiretroviral therapy (HAART), morbidity and mortality rates associated with human immunodeficiency virus (HIV) have significantly decreased leading to prolonged life span of Individuals living with HIV due to the effectiveness of antiretroviral therapy. However, this prolonged lifespan alone does not fully account for the increased incidence of cardiometabolic complications. These complications result from a complex interplay of factors such as chronic inflammation, immune activation, ART‐related metabolic effects, and lifestyle changes. which contribute to elevated morbidity and mortality rates, therefore requiring a deeper understanding and setting effective management strategies. This review aims at providing insights and a nuanced understanding of the relationship between HIV and cardiometabolic disorders, explore their clinical implications and adapt optimal management strategies to address the multifaceted challenges at the intersection of HIV and cardiometabolic health, ultimately enhancing patient outcomes and quality of life.Methods: Data retrieval was conducted using a predetermined search strategy from medical journals that were published in bibliographical databases like PubMed, Science Direct and Embase. This review systematically considered and synthesized current literature on the association between cardiometabolic challenges and HIV.Results: This review provides a detailed exploration of the interrelationship between HIV and cardiometabolic challenges, with an emphasis on insights, impact, and best practices for optimal management. It underscores the high risk of cardiovascular disease, insulin resistance, dyslipidemia, and lipodystrophy in people living with HIV. Recommendations include evidence‐based approaches such as routine cardiometabolic risk. Prevention, screening, management, lifestyle interventions (diet and exercise), and optimizing ART regimens to reduce the negative health outcomes experienced by people living with HIV and to direct clinical practice. To reduce health issues, enhance clinical results, and improve the long‐term quality of life for people living with HIV, it is important to early identify cardiovascular risk factors and to follow customized prevention and management methods.Conclusion: This review shows that early detection through regular screening is pivotal through collaboration between healthcare providers, researchers, and policymakers which will allow for timely interventions and drive innovation and address evolving challenges to enhancing the quality of life for individuals living with HIV. Continuing to do research and advocacy efforts, will not only advance knowledge but also optimize the long‐term health outcomes for people living with HIV.


  • Open Access

    Environmental Factors and Cardiovascular Susceptibility: Toward Personalized Prevention Mediated by the Role of Artificial Intelligence–A Narrative Review

    by Fatima Soufan, Hajar Nasir Tukur, Ruth Girum Tamir, Ernest Muhirwa, Magda Wojtara, Olivier Uwishema

    Background and Purpose: Cardiovascular diseases (CVD) represent a significant global health challenge due to high morbidity and mortality rates, that necessitate approaching the intricate relation between cardiovascular susceptibility and environmental factors, highlighting the importance of creating personalized cardiovascular prevention plans. Furthermore, as it is becoming integrated with the various aspects of healthcare, the role of artificial intelligence in cardiovascular and precision medicine is driving innovations towards personalized care. This review dives into the complex connection between cardiovascular susceptibility and environmental risk highlighting the importance of creating personalized cardiovascular preventive strategies in light of the upcoming artificial intelligence.Methods: An in‐depth review was conducted using PubMed and ScienceDirect, to collect data from all articles that handled environmental factors and cardiovascular susceptibility with special emphasis on the up‐to‐date emerging role of artificial intelligence in preventive strategies.Results: The review revealed high heritability estimates and highlighted the significance of modifiable risk factors which are pivotal determinants affecting CVD susceptibility. The integration of artificial intelligence is implementing the power of precision preventive medicine that can be directed toward specific environmental factors, shifting the whole healthcare system to superior outcomes.Conclusion: Recognizing the preventability of CVD through personalized environmental modifications, this review advocates tailored prevention plans that account for individual characteristics. Despite its proven efficacy in managing modifiable risk factors, achieving optimal cardiovascular health remains challenging, necessitating innovative strategies and the integration of artificial intelligence in personalized healthcare.


  • Open Access

    Noninvasive Assessment of Coronary Artery Disease: Recent Techniques, Diagnostic Accuracy, and Clinical Implications for Modern Cardiology–A Narrative Review

    by Dionysia Kravarioti, Hassan Chaito, Souhail Ouardouz, Elaf Abdulnaser Al‐Saab, Magda Wojtara, Olivier Uwishema

    Background and Aims: Coronary artery disease (CAD), a leading cause of death globally, is among the most commonly diagnosed manifestations of heart disease. Although invasive coronary angiography (ICA) remains the “gold standard” to detect CAD, it is accompanied by several limitations. This review aims to present recent Noninvasive diagnostic modalities in CAD, report and compare the diagnostic accuracy of different invasive and noninvasive tests in CAD, and analyze both the current and future clinical implications of noninvasive modalities that regularly evaluate CAD in modern cardiology.Methods: Given this background and purpose, various, reliable online sources were searched to find relevant data for our narrative review. To this end, several databases were consulted including Google Scholar, PubMed, and Embase.Results: The weight of the evidence highlights that the accuracy of several noninvasive diagnostic modalities in CAD is high and the choice of the most suitable noninvasive diagnostic testing mainly depends on local resources, tests' features, and patients' characteristics, which determine the pretest probability of CAD. For patients presenting an intermediate pretest probability of the disease noninvasive testing seems to be appropriate.Conclusion: Noninvasive diagnostic modalities could limit the usage of invasive modalities in CAD. Nowadays, noninvasive diagnostic modalities are increasingly being promoted as they provide useful and reliable information about the various aspects of CAD. Undoubtedly, more efforts are needed to optimize noninvasive diagnostic tests to demonstrate their full potential in CAD.


  • Open Access

    Enhancing patient care: pharmacotherapeutic monitoring in community pharmacies – a literature review

    by Samuel Bpharm Inshutiyimana, Laura Mbbs Ghanem, Nagham Ramadan, Doha Bpharm Hammoud, Magda Wojtara, Sarah Bsc Mshaymesh, Olivier Uwishema

    Background: The role of community pharmacies has been transitioning from traditional drug dispensing methods to include more patient-centered services such as pharmacotherapeutic monitoring. With the increasing complexity of medication regimens and the rising prevalence of chronic diseases, pharmacotherapeutic monitoring plays a crucial role in preventing medication-related problems. This study aims to review patient outcomes of community pharmacies’ involvement in pharmacotherapeutic monitoring services. It also highlights advances in the monitoring process, the challenges involved, and relevant solutions. Methods: A narrative review was conducted from 8 April 2024 to 9 May 2024, where data were extracted from multiple research studies indexed in PubMed, EBSCOHost, and Google Scholar databases. This review included only previous articles written in English and had information relevant to community pharmacy, patient care, innovations in pharmacotherapeutic monitoring, and challenges associated with the monitoring process in community pharmacies. Results: Implementation of pharmacotherapeutic monitoring in community pharmacies improves patient outcomes and satisfaction. It minimizes adverse events by ensuring optimal dosing and patient adherence, which in turn reduces medical expenses and duration of hospitalization. However, factors such as inefficient analytical resources, lack of skilled personnel, and huge financial costs complicate implementation of pharmacotherapeutic monitoring in community pharmacies. Conclusion: Community pharmacies’ participation in therapeutic drug monitoring is a promising development that prioritizes tailored patient care, eliminating the need for hospital visits. We recommend a multidisciplinary collaboration, robust electronic medical record systems, and large-scale research studies to provide sufficient evidence on the application of therapeutic drug monitoring in community pharmacies, to leverage this service. Also, policy and decision-makers should facilitate this practice by investing more in pharmacotherapeutic monitoring tools and training for community pharmacists.


  • Open Access

    The Role of Cardiac Resynchronization Therapy in Heart Failure: A Narrative Review

    by Olivier Uwishema, Ece Karabulut, Dalal Sheikhah, Burhan Kantawala, Misgana Gallo, Fatima Soufan, Magda Wojtara

    Introduction: Structural and functional cardiac defects leading to inadequate tissue oxygenation is known as Heart failure (HF) which is characterized by extensive morbidity and mortality. Pathophysiology of HF involves systolic and diastolic dysfunction, neurohormonal dysregulation, and imbalance in inflammatory mediators which complicates treatment further. Cardiac resynchronization therapy (CRT) is an approach used for restoring ventricular synchrony and enhancing mechanical efficiency. This study discusses various key points of CRT and its uses in HF and discusses challenges and future implications. Methods: An extensive review of the literature was conducted with evidence from several databases like Medline, PubMed Central, and Embase. Preference was given to articles published after 2010, but relevant articles even pre‐2010 were included. Mendeley was used as a reference manager for formatting. Results: Functional improvements and an enhanced quality of life across a diverse range of patients have been demonstrated using CRT. This has significantly impacted the mortality rates of patients with HF. This manuscript conducted a comparative analysis various hallmark clinical trials conducted in lieu of CRT, across many years (2002, 2003, 2004, 2005, 2017, 2018, 2020). All trials have noted the supremacy of CRT compared to pharmaceutical treatment or other therapeutic methods. Majority of the trial participants had an LVEF of ≤ 35%, a QRS duration of ≤ 150 ms, and were categorized as NYHA class II–IV before initiation of CRT and, posttreatment, LVEF was improved significantly. The main advantages noted were functional improvements, such as enhanced quality of life and reduced mortality. Conclusion: There have been multiple efforts undertaken to address the challenges in CRT, which include a reduction in the rates of nonresponding patients and using alternative adjunctive therapies like defibrillators. These have been shown to improve outcomes among HF patients. Although CRT is noted to be very efficient, some challenges like technological limitations, uncertainty regarding optimal pacing, and nonresponding patients, exist. Ongoing research aims to further develop and revolutionize HF care and improve patient outcomes across the world by refining patient selections and CRT efficacy.

  • Open Access

    The Role of Telemedicine in Enhancing Surgical Care Delivery in Africa: A Literature Review

    by Alicia Kwan Su Huey, Aman Singh Sengar, Zeinab Kazan, Karan Choudhary, Raj Pravin Patel, Magda Wojtara, Olivier Uwishema

    Background and Aims: In Africa, telemedicine holds great potential to revolutionize surgical care delivery, especially in areas where access to quality treatment is scarce. Data about the use of these services in African countries is, however, limited. To outline the present issues in surgical care delivery, as well as the significant role of telemedicine in advancing surgical care delivery in Africa. This review will also discuss the challenges behind telemedicine utilization in Africa, and recommend targeted measures to address those barriers while promoting the enhanced integration of telemedicine into surgical care delivery.Methods: A comprehensive online literature search was conducted using several search engines, including PubMed, ScienceDirect, and Google Scholar to assess the potential advantages of telemedicine over traditional surgical practices in Africa, as well as to identify the challenges hindering its implementation. The literature review examined the role of nongovernmental organizations in promoting telemedicine adoption across various African countries. Literature search terms include “countries of Africa,” “impact of telesurgery and telemedicine in Africa,” and “current situation of telemedicine in intervention.” Only articles written in English were considered, and inclusion criteria included relevance to our research objectives and countries in Africa.Results: The potential for telesurgery in Saharan and sub‐Saharan countries is still a milestone to be unlocked, but already telemedicine implementation has shown great results. Although hindrances like trust, lack of infrastructure, and lack of trained personnel in the field of telecommunication have been issues. There is a rise in the use of telemedicine in areas of interest like postsurgical care, doctor‐patient consultation, and tele‐monitoring. Various schemes and plans implemented by public organizations have also peaked since the pandemic. A telemedicine establishment requires multifactorial development occurring in a step‐by‐step manner. Although complexity in development and barriers faced in countries in Africa are concerns, the outcomes of using telemedicine are considerably better. The rising population and lack of medical specialists have led to a gap in access to approachable surgical care, and telemedicine has shown promising potential to overcome it.Conclusion: Telemedicine implementation has changed the method of intervention in clinics all over the world. Implementation of parts of telemedicine like telesurgery and tele‐monitoring has the potential to overcome the concern of a rising population, but there is still a long way to go.